Global Procedures for Fractures and Degenerative Disc Disease (North America, including Canada and the United States; Oceania, including Australia and New Zealand; Latin America, including Argentina, Mexico, Brazil and Other Countries; Europe, including Germany, Frange, the U.K., Italy, Spain, Belgium, the Netherlands, Denmark, Finland, Normway, Sweden, Austria, Switzerland and Portugal.)
Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for North America, including Canada and the United States; Oceania, including Australia and New Zealand; Latin America, including Argentina, Mexico, Brazil and Other Countries; Europe, including Germany, Frange, the U.K., Italy, Spain, Belgium, the Netherlands, Denmark, Finland, Normway, Sweden, Austria, Switzerland and Portugal.
Report Contents:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.
Report Contents:
- Market Forecast and Analysis
- Identify Strategic Opportunities
- Final Review and Market Release
- Customer Feedback and Market Monitoring
- Fractures
- Degenerative Disc Disease
- Avascular Necrosis
- PharMEDium/B. Braun
- International Medical Industries
- Ameridose
- Health Care Logistics
- Baxa Corporation/Baxter International
- Medi-Dose/EPS/Vu-Pak
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.
1.1 IDATA’S 9-STEP METHODOLOGY
1.1.1 Step 1: Project Initiation & Team Selection
1.1.2 Step 2: Prepare Data Systems and Perform Secondary Research
1.1.3 Step 3: Preparation for Interviews & Questionnaire Design
1.1.4 Step 4: Performing Primary Research
1.1.5 Step 5: Research Analysis: Establishing Baseline Estimates
1.1.6 Step 6: Market Forecast and Analysis
1.1.7 Step 7: Identify Strategic Opportunities
1.1.8 Step 8: Final Review and Market Release
1.1.9 Step 9: Customer Feedback and Market Monitoring
FRACTURES
2.1 INTRODUCTION
2.1.1 Incidence of Fractures
2.1.2 Soft Tissue Damage
2.2 NORTH AMERICA
2.2.1 Incidence of Fracture
2.2.2 Fracture Numbers by Type
2.2.3 Osteoporotic Fracture Numbers of the Smoking Population
2.2.4 Osteoporotic Fracture Numbers of the Diabetic Population
2.2.5 Osteoporotic Fracture Numbers of the Glucocorticoid User Population
2.2.6 Fractures with Displacement
2.2.7 Fractures with Soft Tissue Damage
2.3 OCEANIA
2.3.1 Incidence of Fracture
2.3.2 Fracture Numbers by Type
2.3.3 Smoking Fracture Numbers
2.3.4 Diabetes Fracture Numbers
2.3.5 Glucocorticoid User Fracture Numbers
2.3.6 Fractures with Displacement
2.3.7 Fractures with Soft Tissue Damage
2.4 LATIN AMERICA
2.4.1 Incidence of Fracture
2.4.2 Fracture Numbers by Type
2.4.3 Smoking Fracture Numbers
2.4.4 Diabetes Fracture Numbers
2.4.5 Glucocorticoid User Fracture Numbers
2.4.6 Fractures with Displacement
2.4.7 Fractures with Soft Tissue Damage
2.5 EUROPE
2.5.1 Incidence of Fracture
2.5.2 Fracture Numbers by Type
2.5.3 Smoking Fracture Numbers
2.5.4 Diabetes Fracture Numbers
2.5.5 Glucocorticoid Fracture Numbers
2.5.6 Fractures with Displacement
2.5.7 Fractures with Soft Tissue Damage
DEGENERATIVE DISC DISEASE
3.1 INTRODUCTION
3.1.1 Degenerative Disc Disease
3.1.1.1 Disc Herniation
3.1.1.2 Stenosis
3.1.1.3 Spondylolisthesis
3.1.1.4 Arthritis
3.1.2 Vertebral Compression Fracture
3.1.2.1 Osteoporosis
3.1.2.2 Vertebral Compression Fractures
3.1.3 Risk Factors
3.1.3.1 Degenerative Disc Disease
3.1.3.2 Vertebral Compression Fracture
3.2 UNITED STATES
3.3 AUSTRALIA
3.4 LATIN AMERICA
3.4.1 Argentina
3.4.2 Brazil
3.4.3 Mexico
3.5 EUROPE
3.5.1 Germany
3.5.2 France
3.5.3 United Kingdom
3.5.4 Italy
3.5.5 Spain
3.5.6 Belgium
3.5.7 Netherlands
3.5.8 Denmark
3.5.9 Finland
3.5.10 Norway
3.5.11 Sweden
3.5.12 Austria
3.5.13 Switzerland
3.5.14 Portugal
AVASCULAR NECROSIS
4.1 INTRODUCTION
4.2 NORTH AMERICA
4.3 OCEANIA
4.4 LATIN AMERICA
4.5 EUROPE
APPENDIX: STATISTICS
5.1 SMOKING STATISTICS
5.1.1 North America
5.1.2 Oceania
5.1.3 Latin America
5.1.4 Europe
5.2 DIABETES STATISTICS
5.2.1 North America
5.2.2 Oceania
5.2.3 Latin America
5.2.4 Europe
ABBREVIATIONS
1.1.1 Step 1: Project Initiation & Team Selection
1.1.2 Step 2: Prepare Data Systems and Perform Secondary Research
1.1.3 Step 3: Preparation for Interviews & Questionnaire Design
1.1.4 Step 4: Performing Primary Research
1.1.5 Step 5: Research Analysis: Establishing Baseline Estimates
1.1.6 Step 6: Market Forecast and Analysis
1.1.7 Step 7: Identify Strategic Opportunities
1.1.8 Step 8: Final Review and Market Release
1.1.9 Step 9: Customer Feedback and Market Monitoring
FRACTURES
2.1 INTRODUCTION
2.1.1 Incidence of Fractures
2.1.2 Soft Tissue Damage
2.2 NORTH AMERICA
2.2.1 Incidence of Fracture
2.2.2 Fracture Numbers by Type
2.2.3 Osteoporotic Fracture Numbers of the Smoking Population
2.2.4 Osteoporotic Fracture Numbers of the Diabetic Population
2.2.5 Osteoporotic Fracture Numbers of the Glucocorticoid User Population
2.2.6 Fractures with Displacement
2.2.7 Fractures with Soft Tissue Damage
2.3 OCEANIA
2.3.1 Incidence of Fracture
2.3.2 Fracture Numbers by Type
2.3.3 Smoking Fracture Numbers
2.3.4 Diabetes Fracture Numbers
2.3.5 Glucocorticoid User Fracture Numbers
2.3.6 Fractures with Displacement
2.3.7 Fractures with Soft Tissue Damage
2.4 LATIN AMERICA
2.4.1 Incidence of Fracture
2.4.2 Fracture Numbers by Type
2.4.3 Smoking Fracture Numbers
2.4.4 Diabetes Fracture Numbers
2.4.5 Glucocorticoid User Fracture Numbers
2.4.6 Fractures with Displacement
2.4.7 Fractures with Soft Tissue Damage
2.5 EUROPE
2.5.1 Incidence of Fracture
2.5.2 Fracture Numbers by Type
2.5.3 Smoking Fracture Numbers
2.5.4 Diabetes Fracture Numbers
2.5.5 Glucocorticoid Fracture Numbers
2.5.6 Fractures with Displacement
2.5.7 Fractures with Soft Tissue Damage
DEGENERATIVE DISC DISEASE
3.1 INTRODUCTION
3.1.1 Degenerative Disc Disease
3.1.1.1 Disc Herniation
3.1.1.2 Stenosis
3.1.1.3 Spondylolisthesis
3.1.1.4 Arthritis
3.1.2 Vertebral Compression Fracture
3.1.2.1 Osteoporosis
3.1.2.2 Vertebral Compression Fractures
3.1.3 Risk Factors
3.1.3.1 Degenerative Disc Disease
3.1.3.2 Vertebral Compression Fracture
3.2 UNITED STATES
3.3 AUSTRALIA
3.4 LATIN AMERICA
3.4.1 Argentina
3.4.2 Brazil
3.4.3 Mexico
3.5 EUROPE
3.5.1 Germany
3.5.2 France
3.5.3 United Kingdom
3.5.4 Italy
3.5.5 Spain
3.5.6 Belgium
3.5.7 Netherlands
3.5.8 Denmark
3.5.9 Finland
3.5.10 Norway
3.5.11 Sweden
3.5.12 Austria
3.5.13 Switzerland
3.5.14 Portugal
AVASCULAR NECROSIS
4.1 INTRODUCTION
4.2 NORTH AMERICA
4.3 OCEANIA
4.4 LATIN AMERICA
4.5 EUROPE
APPENDIX: STATISTICS
5.1 SMOKING STATISTICS
5.1.1 North America
5.1.2 Oceania
5.1.3 Latin America
5.1.4 Europe
5.2 DIABETES STATISTICS
5.2.1 North America
5.2.2 Oceania
5.2.3 Latin America
5.2.4 Europe
ABBREVIATIONS
